Talis Biomedical Corp
OTC:TLIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Talis Biomedical Corp
OTC:TLIS
|
US |
|
Crestchic PLC
LSE:LOAD
|
UK |
|
Ely Gold Royalties Inc
OTC:ELDCF
|
CA |
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
JP |
|
D
|
Dexcom Inc
XMUN:DC4
|
US |
|
Devro PLC
LSE:DVO
|
UK |
|
I
|
Interpublic Group of Companies Inc
SWB:IPG
|
US |
|
People.cn Co Ltd
SSE:603000
|
CN |
Shareholder Yield
Current shareholder yield for TLIS is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
TLIS Price
Talis Biomedical Corp
| Average Annual Return | -51.12% |
| Standard Deviation of Annual Returns | 44.1% |
| Max Drawdown | -99% |
| Market Capitalization | 5.2m USD |
| Shares Outstanding | 1 820 000 |
| Percentage of Shares Shorted | 1.54% |
TLIS Return Decomposition
Main factors of price return
Stock Splits
TLIS's latest stock split occurred on Jul 6, 2023
The company executed a 1-for-15 stock split, meaning that for every 15 shares held, investors received 1 new share.
Before the split, TLIS traded at 0.498 per share. Afterward, the share price was about 7.36.
The adjusted shares began trading on Jul 6, 2023. This was the only stock split in TLIS's history.
